Effect of Anti-Inflammatory Agents on Biological Responses to Endotoxin Inhalation in Healthy Subjects

NCT02252809 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Innate Immunity

Interventions

DRUG: adalimumab
DRUG: methylprednisolone

Sponsor

Brugmann University Hospital